Zkusit zdarma
Coherus Oncology, Inc.

Coherus Oncology, Inc.

CHRS
Cena:
$ 1.61
+0.04 (2.55%)
Valuace
70
Růst
0
Zdraví
63
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Coherus Oncology: Setting Up For Important Readouts In Mid-2026

Coherus Oncology: Setting Up For Important Readouts In Mid-2026

6:00 13-05-2026

Coherus Oncology (CHRS) remains a Buy as I maintain optimism around its advancing immunotherapy pipe...

Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call Transcript

Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call Transcript

9:50 12-05-2026

Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call Transcript...

Coherus Oncology Q1 Earnings Call Highlights

Coherus Oncology Q1 Earnings Call Highlights

19:07 11-05-2026

Coherus Oncology NASDAQ: CHRS said it expects revenue growth for its nasopharyngeal cancer drug LOQT...

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

19:06 11-05-2026

Coherus Oncology (CHRS) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus...

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

16:05 11-05-2026

– LOQTORZI® net revenue of $11.8 million in Q1 2026 – – Patient accrual complete for 1L HCC P...

Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026

Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026

9:30 04-05-2026

REDWOOD CITY, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today...

Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know

Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know

13:01 25-03-2026

Coherus Oncology (CHRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism abou...

Coherus Oncology, Inc. (NASDAQ:CHRS) Receives $5.51 Consensus Target Price from Brokerages

Coherus Oncology, Inc. (NASDAQ:CHRS) Receives $5.51 Consensus Target Price from Brokerages

1:40 16-03-2026

Shares of Coherus Oncology, Inc. (NASDAQ: CHRS - Get Free Report) have received an average rating of...

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

20:57 09-03-2026

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript...

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

18:36 09-03-2026

Coherus Oncology (CHRS) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus...

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

16:15 09-03-2026

– LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 –...

Coherus Oncology to Participate in Upcoming Investor Conferences

Coherus Oncology to Participate in Upcoming Investor Conferences

9:30 23-02-2026

REDWOOD CITY, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today ...

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

16:11 17-02-2026

–The Offering was led by healthcare-dedicated investors including Janus Henderson Investors, HBM H...

Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Rating of “Hold” by Analysts

Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Rating of “Hold” by Analysts

3:19 16-02-2026

Shares of Coherus Oncology, Inc. (NASDAQ: CHRS - Get Free Report) have received an average recommend...

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

21:18 12-02-2026

REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the...

Coherus Oncology (NASDAQ:CHRS) Share Price Crosses Above 200-Day Moving Average – What’s Next?

Coherus Oncology (NASDAQ:CHRS) Share Price Crosses Above 200-Day Moving Average – What’s Next?

3:18 31-01-2026

Coherus Oncology, Inc. (NASDAQ: CHRS - Get Free Report)'s share price crossed above its two hundred ...

Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

16:16 13-01-2026

Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript...

Coherus Oncology (NASDAQ:CHRS) Stock Passes Above 200 Day Moving Average – Should You Sell?

Coherus Oncology (NASDAQ:CHRS) Stock Passes Above 200 Day Moving Average – Should You Sell?

3:06 09-01-2026

Coherus Oncology, Inc. (NASDAQ: CHRS - Get Free Report) crossed above its two hundred day moving ave...

Coherus Oncology: A Two-Pronged March With Mid-2026 Implications

Coherus Oncology: A Two-Pronged March With Mid-2026 Implications

11:06 23-12-2025

Coherus Oncology maintains a 'Buy' rating, driven by a promising clinical pipeline and undervaluatio...

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma

8:30 08-12-2025

-6 Years Long-term survival data reinforce potential benefit to patient survival in treating recurre...

close

COHERUS ONCOLOGY, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

12-02-2026
REDWOOD CITY, CALIF., FEB. 12, 2026 (GLOBE NEWSWIRE) -- COHERUS ONCOLOGY, INC. (“COHERUS” OR THE...
Více zde

COHERUS MANAGEMENT TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2026
REDWOOD CITY, CALIF., JAN. 06, 2026 (GLOBE NEWSWIRE) -- COHERUS ONCOLOGY, INC. (NASDAQ: CHRS) TODAY ...
Více zde

COHERUS ONCOLOGY ANNOUNCES PUBLICATION IN MOLECULAR CANCER THERAPEUTICS HIGHLIGHTING THE STRONG PHARMACOLOGY OF INVESTIGATIONAL CCR8 ANTIBODY TAGMOKITUG (CHS-114)

05-01-2026
-COHERUS ONCOLOGY FORMALLY INTRODUCES NON-PROPRIETARY NAME:  TAGMOKITUG- -PUBLICATION SHOWS PICOMOL...
Více zde

COHERUS ANNOUNCES SIX-YEAR JUPITER-02 FOLLOW-UP RESULTS SHOWING LOQTORZI® PLUS CHEMOTHERAPY NEARLY DOUBLES MEDIAN OVERALL SURVIVAL IN NASOPHARYNGEAL CARCINOMA

08-12-2025
-6 YEARS LONG-TERM SURVIVAL DATA REINFORCE POTENTIAL BENEFIT TO PATIENT SURVIVAL IN TREATING RECURRE...
Více zde

COHERUS ONCOLOGY PRESENTS AT SITC CLINICAL MULTIOMIC BIOMARKER DATA FOR CHS-114, A HIGHLY SELECTIVE ANTI-CCR8 CYTOLYTIC ANTIBODY

07-11-2025
– CHS-114 DEMONSTRATED ROBUST AND SELECTIVE DEPLETION OF CCR8+ TREGS AS WELL AS FAVORABLE IMMUNE R...
Více zde

COHERUS ONCOLOGY REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

06-11-2025
– CHS-114, A HIGHLY SELECTIVE TREG DEPLETER, CLINICAL PROGRAM EXPANDED TO INCLUDE COLORECTAL CANCE...
Více zde

ARVIND SOOD JOINS COHERUS ONCOLOGY AS CHIEF STRATEGY AND CORPORATE AFFAIRS OFFICER

06-11-2025
–  RESPONSIBLE FOR CORPORATE DEVELOPMENT, INVESTOR RELATIONS, GOVERNMENT AFFAIRS – REDWOOD CITY...
Více zde

COHERUS ONCOLOGY TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 6, 2025

30-10-2025
REDWOOD CITY, CALIF., OCT. 30, 2025 (GLOBE NEWSWIRE) -- COHERUS ONCOLOGY, INC. (NASDAQ: CHRS), TODA...
Více zde

COHERUS ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

23-10-2025
REDWOOD CITY, CALIF., OCT. 23, 2025 (GLOBE NEWSWIRE) -- COHERUS ONCOLOGY, INC. (NASDAQ: CHRS) TODAY ...
Více zde

COHERUS ONCOLOGY ANNOUNCES POSTER PRESENTATION AT THE 40TH ANNUAL MEETING OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC)

03-10-2025
– CHS-114, AN ANTI-CCR8 CYTOLYTIC ANTIBODY, WILL ALSO BE FEATURED IN SITC'S UPCOMING WEBINAR SERIE...
Více zde

COHERUS ONCOLOGY REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

07-08-2025
– LOQTORZI NET REVENUE WAS $10.0 MILLION, A 36% INCREASE OVER Q1 2025 – – DATA READOUTS FOR CH...
Více zde

COHERUS ONCOLOGY TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 7, 2025

31-07-2025
REDWOOD CITY, CALIF., JULY 31, 2025 (GLOBE NEWSWIRE) -- COHERUS ONCOLOGY, INC. (COHERUS, COHERUS ON...
Více zde

COHERUS BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

12-05-2025
– STRATEGIC TRANSFORMATION TO INNOVATIVE ONCOLOGY COMPLETED IN Q2 2025 – – POSITIVE CHS-114 (A...
Více zde

COHERUS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 12, 2025

05-05-2025
REDWOOD CITY, CALIF., MAY 05, 2025 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” NA...
Více zde

COHERUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

01-05-2025
REDWOOD CITY, CALIF., MAY 01, 2025 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” NA...
Více zde

COHERUS PRESENTS PROMISING EARLY CLINICAL DATA FROM PHASE 1 DOSE EXPANSION STUDY OF CHS-114 IN PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA AT AACR 2025

28-04-2025
– CHS-114 DEMONSTRATES CLINICAL EFFICACY AND PROOF OF MECHANISM IN HNSCC IN COMBINATION WITH TORIP...
Více zde

COHERUS COMPLETES STRATEGIC TRANSFORMATION WITH SUCCESSFUL DIVESTITURE OF UDENYCA® FRANCHISE

14-04-2025
– $250 MILLION POST-CLOSE CASH BALANCE EXTENDS CASH RUNWAY OVER TWO YEARS INTO 2027, FUNDING PIPEL...
Více zde

COHERUS TO PRESENT DATA FROM A PHASE 1 DOSE EXPANSION STUDY OF CHS-114, A CYTOLYTIC ANTIBODY TARGETING CHEMOKINE RECEPTOR 8 (CCR8), AT THE 2025 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING

25-03-2025
REDWOOD CITY, CALIF., MARCH 25, 2025 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” ...
Více zde

COHERUS BIOSCIENCES REPORTS FOURTH QUARTER, FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

10-03-2025
– ANNUAL NET REVENUE INCREASED 4% TO $267.0 MILLION IN 2024, DESPITE SIGNIFICANT DIVESTITURES –...
Více zde

COHERUS TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON MARCH 10, 2025

03-03-2025
REDWOOD CITY, CALIF., MARCH 03, 2025 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” ...
Více zde

COHERUS MANAGEMENT TO PARTICIPATE AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

24-02-2025
REDWOOD CITY, CALIF., FEB. 24, 2025 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” N...
Více zde

COHERUS TO PRESENT FINAL PHASE 2 CASDOZOKITUG COMBINATION DATA IN PATIENTS WITH METASTATIC HEPATOCELLULAR CARCINOMA AT ASCO-GI 2025

18-12-2024
- RANDOMIZED PHASE 2 STUDY INITIATED EVALUATING THE COMBINATION OF CASDOZOKITUG, TORIPALIMAB AND BEV...
Více zde

COHERUS MANAGEMENT TO PARTICIPATE IN THE 2024 CITI GLOBAL HEALTHCARE CONFERENCE

27-11-2024
REDWOOD CITY, CALIF., NOV. 27, 2024 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” N...
Více zde

COHERUS BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

06-11-2024
–  NET REVENUE OF $70.8 MILLION IN Q3  2024 DRIVEN BY 30% INCREASE IN UDENYCA ®   NET REVENUE,...
Více zde

COHERUS TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON NOVEMBER 6, 2024

30-10-2024
REDWOOD CITY, CALIF., OCT. 30, 2024 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” N...
Více zde

COHERUS TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 8, 2024

01-08-2024
REDWOOD CITY, CALIF., AUG. 01, 2024 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (“COHERUS,” N...
Více zde

COHERUS BIOSCIENCES ANNOUNCES DIVESTITURE OF YUSIMRY (ADALIMUMAB-AQVH) IN A $40 MILLION UPFRONT ALL CASH TRANSACTION

27-06-2024
– TRANSACTION ALIGNS WITH COHERUS' STRATEGIC FOCUS ON ONCOLOGY – – TRANSACTION ALIGNS WITH COH...
Více zde

COHERUS MANAGEMENT TO PRESENT AT THE 2024 JEFFERIES GLOBAL HEALTHCARE CONFERENCE

30-05-2024
REDWOOD CITY, CALIF., MAY 30, 2024 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (COHERUS, NASDAQ: C...
Více zde

COHERUS PRESENTS PRELIMINARY RESULTS FROM PHASE I DOSE ESCALATION STUDY OF ITS ANTI-CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODY, CHS-114, AT THE 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

23-05-2024
CHS-114 SHOWN TO HAVE AN ACCEPTABLE SAFETY PROFILE WITH NO DOSE-LIMITING TOXICITIES (DLTS) IN HEAVIL...
Více zde

COHERUS MANAGEMENT TO PRESENT AT THE TD COWEN 5TH ANNUAL ONCOLOGY INNOVATION VIRTUAL SUMMIT: INSIGHTS FOR ASCO & EHA

23-05-2024
REDWOOD CITY, CALIF., MAY 23, 2024 (GLOBE NEWSWIRE) -- COHERUS BIOSCIENCES, INC. (COHERUS, NASDAQ: C...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-04 00:00:008-KStáhnout
2026-01-23 00:00:008-KStáhnout
2026-01-13 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-09-08 01:00:008-KStáhnout
2025-09-08 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-07-03 01:00:008-KStáhnout
2025-07-03 00:00:008-KStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-30 01:00:008-KStáhnout
2025-05-30 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 01:00:0010-QStáhnout
2025-05-12 00:00:008-KStáhnout
2025-05-12 00:00:0010-QStáhnout
2025-04-25 01:00:008-KStáhnout
2025-04-25 00:00:008-KStáhnout
2025-04-22 01:00:008-KStáhnout
2025-04-22 00:00:008-KStáhnout
2025-04-14 01:00:008-KStáhnout
2025-04-14 00:00:008-KStáhnout
2025-04-01 01:00:008-KStáhnout
2025-04-01 00:00:008-KStáhnout
2025-03-17 00:00:0010-KStáhnout
2025-03-16 23:00:0010-KStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-10 00:00:008-KStáhnout
2025-03-09 23:00:008-KStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-03 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-04 00:00:008-KStáhnout
2024-12-03 23:00:008-KStáhnout
2024-12-03 00:00:008-KStáhnout
2024-12-02 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-09-13 01:00:008-KStáhnout
2024-09-13 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-07-02 01:00:008-KStáhnout
2024-07-02 00:00:008-KStáhnout
2024-06-27 01:00:008-KStáhnout
2024-06-27 00:00:008-KStáhnout
2024-06-05 01:00:008-KStáhnout
2024-06-05 00:00:008-KStáhnout
2024-06-04 01:00:008-KStáhnout
2024-06-04 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-03-15 00:00:0010-KStáhnout
2024-03-14 23:00:0010-KStáhnout
2024-03-13 00:00:008-KStáhnout
2024-03-12 23:00:008-KStáhnout
2024-03-04 00:00:008-KStáhnout
2024-03-03 23:00:008-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-05 00:00:008-KStáhnout
2024-02-04 23:00:008-KStáhnout
2024-01-22 00:00:008-KStáhnout
2024-01-21 23:00:008-KStáhnout
2024-01-10 00:00:008-KStáhnout
2024-01-09 23:00:008-KStáhnout
2023-12-27 00:00:008-KStáhnout
2023-12-26 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-12-07 00:00:008-KStáhnout
2023-12-06 23:00:008-KStáhnout
2023-11-27 00:00:008-KStáhnout
2023-11-26 23:00:008-KStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-06 00:00:0010-QStáhnout
2023-11-05 23:00:008-KStáhnout
2023-11-05 23:00:0010-QStáhnout
2023-10-27 01:00:008-KStáhnout
2023-10-27 00:00:008-KStáhnout
2023-10-06 01:00:008-KStáhnout
2023-10-06 00:00:008-KStáhnout
2023-09-12 01:00:008-KStáhnout
2023-09-12 00:00:008-KStáhnout
2023-09-08 01:00:008-KStáhnout
2023-09-08 00:00:008-KStáhnout
2023-08-02 01:00:008-KStáhnout
2023-08-02 01:00:0010-QStáhnout
2023-08-02 00:00:008-KStáhnout
2023-08-02 00:00:0010-QStáhnout
2023-07-20 01:00:008-KStáhnout
2023-07-20 00:00:008-KStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-31 01:00:008-KStáhnout
2023-05-31 00:00:008-KStáhnout
2023-05-18 01:00:008-KStáhnout
2023-05-18 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-06 00:00:0010-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-03-05 23:00:0010-KStáhnout
2023-01-13 00:00:008-KStáhnout
2023-01-12 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-09-15 01:00:008-KStáhnout
2022-09-15 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-05-20 01:00:008-KStáhnout
2022-05-20 00:00:008-KStáhnout
2022-05-13 01:00:008-KStáhnout
2022-05-13 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-04-01 01:00:008-KStáhnout
2022-04-01 00:00:008-KStáhnout
2022-02-23 00:00:0010-KStáhnout
2022-02-22 23:00:0010-KStáhnout
2022-02-17 00:00:008-KStáhnout
2022-02-16 23:00:008-KStáhnout
2022-02-07 00:00:008-KStáhnout
2022-02-06 23:00:008-KStáhnout
2022-01-13 00:00:008-KStáhnout
2022-01-12 23:00:008-KStáhnout
2022-01-07 00:00:008-KStáhnout
2022-01-06 23:00:008-KStáhnout
2021-12-03 00:00:008-KStáhnout
2021-12-02 23:00:008-KStáhnout
2021-11-08 00:00:008-KStáhnout
2021-11-08 00:00:0010-QStáhnout
2021-11-07 23:00:008-KStáhnout
2021-11-07 23:00:0010-QStáhnout
2021-10-13 01:00:008-KStáhnout
2021-10-13 00:00:008-KStáhnout
2021-09-29 01:00:008-KStáhnout
2021-09-29 00:00:008-KStáhnout
2021-08-11 01:00:008-KStáhnout
2021-08-11 00:00:008-KStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-05-26 01:00:008-KStáhnout
2021-05-26 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-02-24 00:00:008-KStáhnout
2021-02-23 23:00:008-KStáhnout
2021-02-12 00:00:008-KStáhnout
2021-02-11 23:00:008-KStáhnout
2021-02-02 00:00:008-KStáhnout
2021-02-01 23:00:008-KStáhnout
2021-01-07 00:00:008-KStáhnout
2021-01-06 23:00:008-KStáhnout
2020-11-18 00:00:008-KStáhnout
2020-11-17 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-05-26 01:00:008-KStáhnout
2020-05-26 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-04-17 01:00:008-KStáhnout
2020-04-17 00:00:008-KStáhnout
2020-04-14 01:00:008-KStáhnout
2020-04-14 00:00:008-KStáhnout
2020-02-27 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:008-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-02-04 00:00:008-KStáhnout
2020-02-03 23:00:008-KStáhnout
2020-01-15 00:00:008-KStáhnout
2020-01-14 23:00:008-KStáhnout
2019-11-08 00:00:0010-QStáhnout
2019-11-07 23:00:0010-QStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-05 23:00:008-KStáhnout
2019-08-05 01:00:0010-QStáhnout
2019-08-05 00:00:0010-QStáhnout
2019-08-01 01:00:008-KStáhnout
2019-08-01 00:00:008-KStáhnout
2019-07-08 01:00:008-KStáhnout
2019-07-08 00:00:008-KStáhnout
2019-05-28 01:00:008-KStáhnout
2019-05-28 00:00:008-KStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 01:00:0010-QStáhnout
2019-05-09 00:00:008-KStáhnout
2019-05-09 00:00:0010-QStáhnout
2019-05-03 01:00:008-KStáhnout
2019-05-03 00:00:008-KStáhnout
2019-04-05 01:00:008-KStáhnout
2019-04-05 00:00:008-KStáhnout
2019-03-19 00:00:008-KStáhnout
2019-03-18 23:00:008-KStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-28 00:00:0010-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-02-27 23:00:0010-KStáhnout
2019-01-11 00:00:008-KStáhnout
2019-01-10 23:00:008-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-11-02 00:00:008-KStáhnout
2018-11-01 23:00:008-KStáhnout
2018-09-26 01:00:008-KStáhnout
2018-09-26 00:00:008-KStáhnout
2018-08-08 01:00:008-KStáhnout
2018-08-08 01:00:0010-QStáhnout
2018-08-08 00:00:008-KStáhnout
2018-08-08 00:00:0010-QStáhnout
2018-07-31 01:00:008-KStáhnout
2018-07-31 00:00:008-KStáhnout
2018-07-17 01:00:008-KStáhnout
2018-07-17 00:00:008-KStáhnout
2018-06-25 01:00:008-KStáhnout
2018-06-25 00:00:008-KStáhnout
2018-05-29 01:00:008-KStáhnout
2018-05-29 00:00:008-KStáhnout
2018-05-25 01:00:008-KStáhnout
2018-05-25 00:00:008-KStáhnout
2018-05-15 01:00:008-KStáhnout
2018-05-15 00:00:008-KStáhnout
2018-05-14 01:00:008-KStáhnout
2018-05-14 00:00:008-KStáhnout
2018-05-10 01:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:008-KStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-05-03 01:00:008-KStáhnout
2018-05-03 00:00:008-KStáhnout
2018-03-26 01:00:008-KStáhnout
2018-03-26 00:00:008-KStáhnout
2018-03-12 00:00:008-KStáhnout
2018-03-11 23:00:008-KStáhnout
2018-03-08 00:00:008-KStáhnout
2018-03-08 00:00:0010-KStáhnout
2018-03-07 23:00:008-KStáhnout
2018-03-07 23:00:0010-KStáhnout
2018-03-06 00:00:008-KStáhnout
2018-03-05 23:00:008-KStáhnout
2018-01-05 00:00:008-KStáhnout
2018-01-04 23:00:008-KStáhnout
2017-12-08 00:00:008-KStáhnout
2017-12-07 23:00:008-KStáhnout
2017-12-05 00:00:008-KStáhnout
2017-12-04 23:00:008-KStáhnout
2017-11-06 00:00:008-KStáhnout
2017-11-06 00:00:0010-QStáhnout
2017-11-05 23:00:008-KStáhnout
2017-11-05 23:00:0010-QStáhnout
2017-09-07 01:00:008-KStáhnout
2017-09-07 00:00:008-KStáhnout
2017-08-29 01:00:008-KStáhnout
2017-08-29 00:00:008-KStáhnout
2017-08-22 01:00:008-KStáhnout
2017-08-22 00:00:008-KStáhnout
2017-08-11 01:00:008-KStáhnout
2017-08-11 00:00:008-KStáhnout
2017-08-07 01:00:008-KStáhnout
2017-08-07 01:00:0010-QStáhnout
2017-08-07 00:00:008-KStáhnout
2017-08-07 00:00:0010-QStáhnout
2017-07-05 01:00:008-KStáhnout
2017-07-05 00:00:008-KStáhnout
2017-06-27 01:00:008-KStáhnout
2017-06-27 00:00:008-KStáhnout
2017-06-26 01:00:008-KStáhnout
2017-06-26 00:00:008-KStáhnout
2017-06-12 01:00:008-KStáhnout
2017-06-12 00:00:008-KStáhnout
2017-05-19 01:00:008-KStáhnout
2017-05-19 00:00:008-KStáhnout
2017-05-12 01:00:008-KStáhnout
2017-05-12 00:00:008-KStáhnout
2017-05-08 01:00:008-KStáhnout
2017-05-08 01:00:0010-QStáhnout
2017-05-08 00:00:008-KStáhnout
2017-05-08 00:00:0010-QStáhnout
2017-04-25 01:00:008-KStáhnout
2017-04-25 00:00:008-KStáhnout
2017-04-10 01:00:008-KStáhnout
2017-04-10 00:00:008-KStáhnout
2017-03-14 00:00:0010-KStáhnout
2017-03-13 23:00:0010-KStáhnout
2017-03-13 00:00:008-KStáhnout
2017-03-12 23:00:008-KStáhnout
2017-03-06 00:00:008-KStáhnout
2017-03-05 23:00:008-KStáhnout
2017-03-03 00:00:008-KStáhnout
2017-03-02 23:00:008-KStáhnout
2017-02-13 00:00:008-KStáhnout
2017-02-12 23:00:008-KStáhnout
2017-01-31 00:00:008-KStáhnout
2017-01-30 23:00:008-KStáhnout
2016-11-30 00:00:008-KStáhnout
2016-11-29 23:00:008-KStáhnout
2016-11-09 00:00:008-KStáhnout
2016-11-09 00:00:0010-QStáhnout
2016-11-08 23:00:008-KStáhnout
2016-11-08 23:00:0010-QStáhnout
2016-11-07 00:00:008-KStáhnout
2016-11-06 23:00:008-KStáhnout
2016-10-28 01:00:008-KStáhnout
2016-10-28 00:00:008-KStáhnout
2016-10-07 01:00:008-KStáhnout
2016-10-07 00:00:008-KStáhnout
2016-10-06 01:00:008-KStáhnout
2016-10-06 00:00:008-KStáhnout
2016-09-27 01:00:008-KStáhnout
2016-09-27 00:00:008-KStáhnout
2016-09-26 01:00:008-KStáhnout
2016-09-26 00:00:008-KStáhnout
2016-08-09 01:00:008-KStáhnout
2016-08-09 01:00:0010-QStáhnout
2016-08-09 00:00:008-KStáhnout
2016-08-09 00:00:0010-QStáhnout
2016-07-11 01:00:008-KStáhnout
2016-07-11 00:00:008-KStáhnout
2016-06-28 01:00:008-KStáhnout
2016-06-28 00:00:008-KStáhnout
2016-06-14 01:00:008-KStáhnout
2016-06-14 00:00:008-KStáhnout
2016-06-03 01:00:008-KStáhnout
2016-06-03 00:00:008-KStáhnout
2016-05-26 01:00:008-KStáhnout
2016-05-26 00:00:008-KStáhnout
2016-05-25 01:00:008-KStáhnout
2016-05-25 00:00:008-KStáhnout
2016-05-18 01:00:008-KStáhnout
2016-05-18 00:00:008-KStáhnout
2016-05-11 01:00:008-KStáhnout
2016-05-11 00:00:008-KStáhnout
2016-05-09 01:00:008-KStáhnout
2016-05-09 01:00:0010-QStáhnout
2016-05-09 00:00:008-KStáhnout
2016-05-09 00:00:0010-QStáhnout
2016-02-29 00:00:008-KStáhnout
2016-02-29 00:00:0010-KStáhnout
2016-02-28 23:00:008-KStáhnout
2016-02-28 23:00:0010-KStáhnout
2016-02-01 00:00:008-KStáhnout
2016-01-31 23:00:008-KStáhnout
2016-01-11 00:00:008-KStáhnout
2016-01-10 23:00:008-KStáhnout
2015-12-21 00:00:008-KStáhnout
2015-12-20 23:00:008-KStáhnout
2015-12-14 00:00:008-KStáhnout
2015-12-13 23:00:008-KStáhnout
2015-12-08 00:00:008-KStáhnout
2015-12-07 23:00:008-KStáhnout
2015-11-10 00:00:0010-QStáhnout
2015-11-09 23:00:0010-QStáhnout
2015-11-09 00:00:008-KStáhnout
2015-11-08 23:00:008-KStáhnout
2015-10-19 01:00:008-KStáhnout
2015-10-19 00:00:008-KStáhnout
2015-10-01 01:00:008-KStáhnout
2015-10-01 00:00:008-KStáhnout
2015-09-14 01:00:008-KStáhnout
2015-09-14 00:00:008-KStáhnout
2015-09-03 01:00:008-KStáhnout
2015-09-03 00:00:008-KStáhnout
2015-08-10 01:00:008-KStáhnout
2015-08-10 01:00:0010-QStáhnout
2015-08-10 00:00:008-KStáhnout
2015-08-10 00:00:0010-QStáhnout
2015-07-08 01:00:008-KStáhnout
2015-07-08 00:00:008-KStáhnout
2015-06-12 01:00:008-KStáhnout
2015-06-12 00:00:008-KStáhnout
2015-05-27 01:00:008-KStáhnout
2015-05-27 00:00:008-KStáhnout
2015-05-11 01:00:008-KStáhnout
2015-05-11 01:00:0010-QStáhnout
2015-05-11 00:00:008-KStáhnout
2015-05-11 00:00:0010-QStáhnout
2015-04-17 01:00:008-KStáhnout
2015-04-17 00:00:008-KStáhnout
2015-04-15 01:00:008-KStáhnout
2015-04-15 00:00:008-KStáhnout
2015-04-14 01:00:008-KStáhnout
2015-04-14 00:00:008-KStáhnout
2015-03-23 00:00:008-KStáhnout
2015-03-23 00:00:0010-KStáhnout
2015-03-22 23:00:008-KStáhnout
2015-03-22 23:00:0010-KStáhnout
2015-03-19 00:00:008-KStáhnout
2015-03-18 23:00:008-KStáhnout
2015-03-11 00:00:008-KStáhnout
2015-03-10 23:00:008-KStáhnout
2014-12-15 00:00:008-KStáhnout
2014-12-15 00:00:0010-QStáhnout
2014-12-14 23:00:008-KStáhnout
2014-12-14 23:00:0010-QStáhnout
2014-12-11 00:00:008-KStáhnout
2014-12-10 23:00:008-KStáhnout
2014-11-13 00:00:008-KStáhnout
2014-11-12 23:00:008-KStáhnout
preloader